Technical Analysis for IRWD - Ironwood Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 10.39 1.07% 0.11
IRWD closed up 1.07 percent on Tuesday, June 25, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IRWD trend table...

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 1.07%
50 DMA Resistance Bearish 1.07%
MACD Bearish Signal Line Cross Bearish 1.07%
Expansion Pivot Sell Setup Bearish Swing Setup 1.07%

Older signals for IRWD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company's lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) gastrointestinal disorders under the LINZESS name in the United States and Constella name in the European Union. It also has a pipeline focused on the research and development of early development candidates and discovery research programs in various therapeutic areas, including gastrointestinal diseases, central nervous system disorders, allergic conditions, and cardiovascular diseases. Ironwood Pharmaceuticals has collaboration and license agreements with Forest Laboratories, Inc. to develop and commercialize linaclotide in North America; Almirall, S.A to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other gastrointestinal conditions; Astellas Pharma Inc. to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other gastrointestinal conditions in Japan, South Korea, Taiwan, Thailand, the Philippines, and Indonesia; and AstraZeneca AB to co-develop and co-commercialize linaclotide in China, including Hong Kong and Macau. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.
Medical Specialties Cardiovascular Diseases Central Nervous System Disorders Gastroenterology Peptides European Union Gastrointestinal Diseases Irritable Bowel Syndrome Digestive Diseases Constipation Gastrointestinal Disorders Human Therapeutic Products Ironwood Pharmaceuticals
Is IRWD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.2
52 Week Low 9.07
Average Volume 1,342,482
200-Day Moving Average 13.1829
50-Day Moving Average 11.0384
20-Day Moving Average 10.982
10-Day Moving Average 10.886
Average True Range 0.5576
ADX 13.07
+DI 25.1377
-DI 28.5193
Chandelier Exit (Long, 3 ATRs ) 10.6972
Chandelier Exit (Short, 3 ATRs ) 11.8728
Upper Bollinger Band 11.6845
Lower Bollinger Band 10.2795
Percent B (%b) 0.08
BandWidth 12.793662
MACD Line -0.1054
MACD Signal Line -0.0584
MACD Histogram -0.047
Fundamentals Value
Market Cap 1.55 Billion
Num Shares 150 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -10.60
Price-to-Sales 8.05
Price-to-Book 441.52
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.17
Resistance 3 (R3) 11.19 10.96 11.04
Resistance 2 (R2) 10.96 10.76 10.95 11.00
Resistance 1 (R1) 10.67 10.64 10.82 10.65 10.95
Pivot Point 10.44 10.44 10.51 10.43 10.44
Support 1 (S1) 10.15 10.24 10.30 10.13 9.83
Support 2 (S2) 9.92 10.12 9.91 9.78
Support 3 (S3) 9.63 9.92 9.74
Support 4 (S4) 9.61